| Not Yet Recruiting | A Phase I Study of SHR-3836 in Patients With Multiple Myeloma Multiple Myeloma | Phase 1 | 2026-04-01 |
| Recruiting | HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors Locally Advanced or Metastatic Pancreatic Cancer With | Phase 1 / Phase 2 | 2026-01-08 |
| Recruiting | A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects Pain | Phase 1 | 2025-12-30 |
| Recruiting | A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors Malignant Solid Tumors | Phase 2 | 2025-12-23 |
| Recruiting | A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors Solid Tumor | Phase 1 / Phase 2 | 2025-12-02 |
| Recruiting | A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer Non-small Cell Lung Cancer | Phase 2 | 2025-11-24 |
| Recruiting | Phase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With Malignant Tumors Patients With Advanced or Metastatic Malignant Tumors | Phase 1 / Phase 2 | 2025-07-24 |
| Recruiting | A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors Advanced Solid Tumors | Phase 2 | 2025-03-28 |
| Recruiting | A Phase III Study of SHR-A2102 Versus Investigator-selected Therapy in Advanced Urothelial Carcinoma Advanced Urothelial Carcinoma | Phase 3 | 2025-02-12 |
| Completed | A Mass Balance Study of [14C] SHR6508 in Chinese Hemodialysis Subjects With Secondary Hyperparathyroidism Secondary Hyperparathyroidism | Phase 1 | 2024-12-23 |
| Not Yet Recruiting | A Phase II Study of SHR-4602 as Montherapy or in Combination With Other Anti-tumor Therapies in Advanced Solid Advanced Solid Tumors | Phase 2 | 2024-12-01 |
| Recruiting | SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Adv Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | Phase 3 | 2024-11-22 |
| Recruiting | A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy Advanced Gynecological Malignancy | Phase 2 | 2024-11-15 |
| Recruiting | A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma Advanced Urothelial Carcinoma | Phase 1 / Phase 2 | 2024-11-04 |
| Recruiting | A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2024-10-04 |
| Recruiting | A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metasta Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2024-09-27 |
| Terminated | Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management in TKA Postoperative Pain Management in Total Knee Arthroplasty | Phase 2 | 2024-08-20 |
| Recruiting | A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-sm Advanced or Metastatic Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2024-07-30 |
| Recruiting | A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esopha Advanced or Metastatic Esophageal Cancer | Phase 1 / Phase 2 | 2024-06-20 |
| Completed | The Trial of SHR6508 in Secondary Hyperparathyroidism Secondary Hyperparathyroidism | Phase 3 | 2024-06-14 |
| Recruiting | Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2024-06-12 |
| Not Yet Recruiting | A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients Wi Advanced Solid Tumors | Phase 1 / Phase 2 | 2024-06-01 |
| Recruiting | SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor CLDN18.2-positive Advanced Solid Tumor | Phase 1 | 2024-05-29 |
| Recruiting | A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2024-05-13 |
| Unknown | Investigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism i Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis | Phase 2 | 2024-02-20 |
| Recruiting | Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients Alzheimer's Disease | Phase 2 | 2024-02-05 |
| Recruiting | A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Intermediate and High-risk Non-muscle Invasive Bladder Cancer | Phase 1 | 2023-11-28 |
| Recruiting | A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's Lymphoma B-cell Non-Hodgkin's Lymphoma | Phase 1 / Phase 2 | 2023-11-17 |
| Completed | A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic D Moderate to Severe Atopic Dermatitis | Phase 2 | 2023-09-06 |
| Recruiting | The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2023-05-18 |
| Unknown | A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2023-04-28 |
| Recruiting | Phase I Study of SHR-A2102 in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2023-04-06 |
| Completed | A Study of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy Postsurgical Pain Management | Phase 3 | 2023-03-21 |
| Active Not Recruiting | A Trial of SHR-7367 in Subjects With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2023-03-06 |
| Unknown | A Phase 1 Study of SHR-A2102 in Subjects With Advanced Solid Tumors. Advanced Or Metastatic Solid Tumor Malignancies | Phase 1 | 2023-03-03 |
| Unknown | A Study of SHR6508 in Secondary Hyperparathyroidism Secondary Hyperparathyroidism | Phase 2 | 2023-02-24 |
| Unknown | Phase Ⅱ Study of Intercostal Nerve Block With HR18034 for Postsurgical Pain Management Thoracoscopic Lobectomy | Phase 2 | 2023-02-21 |
| Completed | Safety, Tolerability and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients. Alzheimer's Disease | Phase 1 | 2023-02-17 |
| Active Not Recruiting | A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma Asthma | Phase 2 | 2023-01-17 |
| Recruiting | A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC High-risk NMIBC | Phase 1 / Phase 2 | 2022-11-23 |
| Unknown | Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management Total Knee Arthroplasty | Phase 2 | 2022-10-20 |
| Completed | Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis Moderate to Severe Atopic Dermatitis | Phase 2 | 2022-10-08 |
| Completed | A Study of HR19024 in Subjects With Advanced Solid Tumor Advanced Solid Tumor | Phase 1 | 2022-08-10 |
| Completed | A Trial of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy. Postsurgical Pain Management | Phase 2 | 2022-06-13 |
| Completed | A Trial of SHR6508 in Secondary Hyperparathyroidism Secondary Hyperparathyroidism | Phase 1 | 2022-03-10 |
| Terminated | Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Unde Prevention of Venous Thrombosis After TKA | Phase 2 | 2022-03-07 |
| Completed | A Study of SHR-A1909 in Subjects With Advanced Malignant Tumors Advanced Malignant Cancer | Phase 1 | 2022-02-23 |
| Unknown | A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MULTIPLE SUBCUTANEOUS Moderate to Severe Atopic Dermatitis | Phase 1 | 2022-01-01 |
| Terminated | A Study of HRS2543 in Patients With Advanced Tumors Advanced Tumors | Phase 1 | 2021-12-28 |
| Unknown | A Study of SHR-A1912 for Injection in Patients With B Cell Lymphomas B Cell Lymphoma | Phase 1 | 2021-12-22 |
| Completed | A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors Advanced Malignant Tumor | Phase 1 | 2021-12-20 |
| Completed | A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children Preoperative Sedation of Children | Phase 3 | 2021-11-24 |
| Unknown | A Phase 1 Study of HRS8807 Monotherapy and in Combination With SHR6390 in Subjects With ER-Positive, HER2-Nega ER-Positive, HER2-Negative Breast Cancer | Phase 1 | 2021-10-26 |
| Unknown | A Trial of SHR-A1904 in Patients With Advanced Pancreatic Cancer Advanced Pancreatic Cancer | Phase 1 | 2021-08-06 |
| Active Not Recruiting | A Study of SHR-A1904 in Patients With Advanced Solid Cancer Advanced Solid Cancer | Phase 1 | 2021-07-01 |
| Completed | A Trial of SHR-1905 in Healthy Subjects and Subjects With Mild Asthma Asthma | Phase 1 | 2021-06-15 |
| Completed | A Study of SHR-1707 in Healthy Young Adult and Elderly Subjects Alzheimer's Disease | Phase 1 | 2021-05-08 |
| Completed | A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Study in Healthy Asthma | Phase 1 | 2021-03-01 |